Skip to main content

Genotyping panel For VTE risk

A product by Ferrer inCode

Ferrer inCode SL provides biotechnological services to help doctors make clinical decisions for patients in the areas of oncology, cardiovascular nutrition, and pharmacology. It engages in promoting and granting access to personalized medicine through diagnosis, prognosis, and prediction-based primarily in genomics proteomics, metabolomics, and bioinformatics technology. The company is based in Barcelona, Spain. Ferrer inCode SL operates as a subsidiary of Grupo Ferrer Internacional S.A. privately-held pharmaceutical company presence in more than 90 countries